Rep. Schrader Votes for Increased Transparency in Prescription Drug Pricing
October 28, 2019
October 28, 2019
WASHINGTON, Oct. 28 -- Rep. Kurt Schrader, D-Oregon, issued the following news release:
Congressman Kurt Schrader (OR-05) voted today for the bipartisan, Public Disclosure of Drug Discounts Act after working to improve the bill through the Energy & Commerce Committee process.
This bill would be a commonsense step to lower the cost of prescription drugs by requiring greater transparency from pharmacy benefit managers (PBMs) the middlemen who negotiate prices for thr . . .
Congressman Kurt Schrader (OR-05) voted today for the bipartisan, Public Disclosure of Drug Discounts Act after working to improve the bill through the Energy & Commerce Committee process.
This bill would be a commonsense step to lower the cost of prescription drugs by requiring greater transparency from pharmacy benefit managers (PBMs) the middlemen who negotiate prices for thr . . .